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Abstract—(Workers in plants producing carbon anodes for aluminium electrolysis are exposed to
PAHs containing coal tar pitch volatiles, pitch and coke. The aim of this study was to evaluate
the suitability of urinary 1-hydroxypyrene to characterize respiratory exposure to PAH, which is
most relevant for assessing individual health risks. Six workers in a carbon anode plant
volunteered to take part in a personal air sampling and a biological monitoring programme
lasting five consecutive 8-h shifts to determine occupational exposure to airborne PAHs and
urinary excretion of 1-hydroxypyrene. Exposure to total PAH for all worksites varied from 3.99
to 120.6 ug PAH m"* and for benzo(a)pyrene (BaP) from 0.17 to 4.88 /ig BaP m~3. The
concentration of 1-hydroxypyrene in post- and pre-shift urine samples was in the range (0.5-
61.8 iano\ 1-OHP per mol creatinine) and depended on the worksite. The Spearman rank
correlation test showed a low but significant (P<0.05) correlation of urinary 1-hydroxypyrene in
the post- and pre-shift samples with respiratory pyrene exposure. The quantitative aspects of
biological monitoring for the evaluation of respiratory PAH exposure were tested with a
pharmflcokinetic model. On the basis of individual pyrene exposure, excretion of urinary 1-
hydroxypyrene during the working week was calculated for each worker. The results presented in
this investigation indicate that biological monitoring of the pyrene metabolite 1-hydroxypyrene is
a useful indicator of a general PAH exposure, but cannot replace personal air sampling for
assessing the lung cancer risk of individuals^ Copyright © 1996 BOHS. Published by Elsevier
Science Ltd.
INTRODUCTION
Polycyclic aromatic hydrocarbons (PAHs) are associated with industrial processes in
which carbonaceous materials such as coke, coal tar, coal tar pitch and asphalt oils
are produced or used (Bjerseth and Becher, 1986). The International Agency for
Research on Cancer (IARC, 1983) classified occupational exposure to PAH-
containing coal tar pitch volatiles in coal gasification plants and in coke production
as carcinogenic to humans. They concluded that there is limited evidence of
carcinogenicity to humans in the aluminium production industry.
In addition to respiratory exposure to PAHs at workplaces, dermal contact with
PAH-containing material seems to be an important route of entry into the organism
(Jongeneelen et al, 1988; Van Rooij et al., 1992). Van Rooij et al. (1993) reported
that in the case of coke oven workers, 75% (range 28-95%) of the total absorbed
pyrene, a PAH congener, enters through the skin.
'Author to whom correspondence should be addressed.
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To estimate the total uptake (internal dose) of PAHs, several groups have
suggested determining the concentration of the major metabolite of pyrene, 1-
hydroxypyrene, in urine as an indicator of PAH exposure (Jongeneelen et al., 1988;
Clonfero et al., 1989; Tolos et al., 1990; Buckley and Lioy, 1992; Boogart and van
Sittert, 1994). Since the PAH profile for an industrial process such as aluminium
production by the Soderberg process or coke distillation is relatively constant, the
determination of one congener (pyrene) is used to represent the total PAH content
for a specific process (Jongeneelen et al., 1993).
In a further step, an empirical mathematical relationship was used to relate air
sampling data and biological monitoring data. Jongeneelen (1992) calculated a
urinary concentration of 1-hydroxypyrene of 2.3 jonol per mol creatinine after a 3-
day working period in coke oven workers. This is assumed to equal the lung cancer
risk of the existing threshold limit values of 2 fig BaP m~3 and 0.2 mg BSM m~3.
Several epidemiological studies have shown that lung cancer is the most relevant
health effect of occupational PAH exposure.
The aim of this study was to determine whether measurement of the urinary
concentration of 1-hydroxypyrene is suitable to estimate respiratory exposure at
work. To this end, six workers of the green section of a carbon anode plant were
monitored during a five-shift working week with personal sampling and biological
monitoring. During the work week, the airborne concentration of 26 PAHs and the
concentration of 1-hydroxypyrene of the post- and pre-shift urine were determined
for each worker.
MATERIALS AND METHODS
Plant description
Carbon anodes are used in aluminium production in the pre-bake anode process,
the carbon anodes are produced in a carbon plant which is separated from the
potrooms. The anode plant in this study was divided into three main sections: the
green anode section; the oven area; and the anode rodding sections. In the green
anode section, coke (calcined petroleum coke) is ground to a specific particle size and
blended with a binder of liquid petroleum pitch to form a semi-solid mixture (paste
plant), which is then pressed in the forming section to the green anode. Although this
process is largely automated, employees working in these sections are exposed to
PAH-containing coal tar pitch volatiles, pitch and coke. In the oven area, the green
anodes are baked in ovens for several days at a temperature of approximately
1400°C. The volatiles and participates are either kept under pressure in the ovens
where they are burned as fuel, or removed and passed through a filter system. After
baking, the carbon anode blocks are moved to the burned anode cleaning section,
where they are fitted onto rods. In the furnace and anode rodding section, exposure
to PAHs occurs to a much lesser extent than in the green anode section.
Study design
In the green anode section of the plant, six workers volunteered to participate in
the study. They belonged to the same crew and represented operating, maintenance
and supervisory personnel. During a 5-day working week, these workers were
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monitored with personal air sampling and biological monitoring. Personal air
samples of each of these workers were taken every day during an 8-h shift. The daily
activities at the different worksites of each worker were carefully registered. In
addition, before (7.30 am) and immediately after the shift (4 pm), urine samples were
taken. The job description of the workers at the different worksites is given in
Table 1.
Personal air sampling
Personal air sampling was carried out for each worker of the crew in each
working shift (8.00-16.00) during a five-shift working week. The sampling equipment
comprised a personal sampling pump (SKC Inc., Valley View, U.S.A.) and a GGP-
system (Gesamtstaub-Gas-Probenahmekopf) developed by the BIA (Berufsgenos-
senschaftliches Institut fur Arbeitssicherheit, Germany). It is possible to collect total
particulate onto a glass fibre filter followed by a silver membrane, and volatile
compounds with an XAD-2 adsorbent tube in line. Prior to sampling, the personal
air sampling pumps were calibrated with a rotameter and a nominal flow rate of
3.5 1. min"1, which corresponds to a suction velocity of 1.25 m s"1. The calibration
of the pumps was checked after sampling, and if the difference exceeded 10% of the
flow rate the sample was not taken into account. The air samples were taken at
breathing height in accordance with the regulations. After sampling the filters and
XAD-2 adsorbent tube were wrapped in aluminium foil and stored at — 20°C until
analysis.
The filters and the adsorbent were extracted overnight with cyclohexane in a
soxhlet apparatus. The extracts were filtered over silica gel and evaporated to a final
volume of 200-500 /J. The detailed description of the analytical procedure is
described elsewhere (Petry el al., 1994).
A total of 26 PAHs, including the 16 PAHs according to NIOSH Method 5506,
were analysed by the combination of gas chromatography-mass spectrometry. A gas
chromatography HRGC 5160 (Carlo Erba, Milan, Italy) equipped with a constant
pressure-constant flow unit (CP-CF 516) was used. Separation was performed on a
20 m x 0.3 mm glass capillary coated with polysiloxane PSO86 (film thickness 0.2 /an,
Huls America Inc.). The carrier gas was hydrogen at a linear flow rate of 50 cm s~'.
Samples were injected 'on column' at 80°C. After 1 min, the temperature was raised
to 200°C at 20°C min"1 and then to a final temperature of 320°C at 5°C min"1. The
interface between the gas chromatograph and the mass spectrometer was a 0.15 mm
Table 1. Description of the worksites participating in this study
Worksite Job description
Truck driver and control functions
Floor worker, operating and maintenance
functions
Crane operator
Truck driver and operating functions
Crane operator, Floor worker
Foreman; operating, control and
maintenance functions
Worker 1
Worker 2
Worker 3
Worker 4
Worker 5
Worker 6
Forming section
Paste plant
Store Section (broken green anodes and
burned anodes)
Forming section
Store section (coke) paste plant
All worksites (mainly paste plant)
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i.d. persilylated piece of fused silica capillary kept at 300°C. The mass spectrometer
(model 4510, Finnigan, Sunnyvale, California, U.S.A.) was run in electron impact
ionization mode and detection of the positive ions. The temperature of the ion source
was held at 190°C. The ionization energy was set to 70 eV and the electromultiplier
to -1700 V. The GC-MS was operated in multiple ion detection (MID) mode for
the following m/z values: 128, 136, 152, 154, 164, 166, 178, 188, 202, 228, 234, 240,
252, 264, 276, 278, 300. Quantification was based on signal heights in the mass
chromatograms. The method had a 10% precision level and a quantification limit of
1 ng m~3 at a sampling volume 1.5 m3.
The following polycyclic aromatic hydrocarbons (abbreviation given in parenth-
esis) were analysed in the workers personal samples: naphthalene (naph)
acenaphytylene (Aceny), acenaphthene (Ace), fluorene (Flu), phenanthrene (Phe),
antracene (Ant), fluoranthene (Fluor), pyrene (Pyr), benzonaphtho(2.1-d) thiophene
(BNT), benzo(ghi)fluoranthene (BghiFl) benzo(c)phenanthrene (BcP), benzo(a)an-
thracene (BaA), chrysene (Chr), benzo(b + j)fluoranthene (BjbF), benzo(k)fluor-
anthene (BkF), benzo(e)pyrene (BeP), benzo(a)pyrene (BaP), perylene (Per),
idenol(1.2.3-cd)pyrene (IND), dibenzo(ac)anthracene (DacA), dibenzo(ah)anthra-
cene (DahA), benzo(b)chrysene (BbQ, 278 (not identified), benzo(ghi)perylene
(BgP), anthanthrene (ANT) and coronene (Cor).
Biological monitoring
During the working week, urine samples of each of the workers were collected
before (7.30 am) and immediately after the workshift (4 pm). The urine samples were
stored in plastic bottles at — 20°C until analysis.
According to the method of Jongeneelen et al. (1987) and Gardiner et al. (1992),
10 ml of urine was adjusted to a pH of 5.0 with 1 N hydrochloric acid and 0.1 M
acetate buffer (pH 5.0) was added to a final volume of 30 ml. This mixture was
incubated overnight (16 h) with 15 fi\ of glucoronidase-arylsulphatase (Bohringer,
Mannheim, Germany) at 37°C in an electronically controlled rotary shaking bath. A
sample enrichment and purification cartridge, packed with C18 reversed-phase liquid
chromatographic material (Sep-Pak C18 cartridge, Waters, Milford, Massachusetts,
U.S.A.), was used for the extraction of the metabolites. Before extraction the
cartridge was primed with 5 ml of methanol, followed by 10 ml of distilled water. The
treated urine was passed through the cartridge at a flow rate of approximately
10 ml min~'. The cartridge was washed with 3 ml of distilled water and 3 ml of 50%
methanol in water. Final elution of 1-hydroxypyrene was performed with 8 ml
methanol. The solution was evaporated to dryness and reconstituted with 1 ml of
methanol.
The HPLC system comprised a Hewlett-Packard 1090 liquid chromatograph
with an autoinjector and a Hitachi F1000 fluorescence detector. The extracts
(25 /il) were injected onto a 250x4.0 mm column of LiChrosorb RP-18 (Knaur,
Berlin, Germany). Column temperature was 40°C and flow rate 0.8 ml min""1. The
solvent gradient was 5 min of methanol-water (46:54), a linear gradient in 35 min
to methanol-water (94:6) followed by 10 min holding. The excitation wavelength
of the fluorescence detector was set to 242 nm and the emission wavelength to
388 nm.
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For establishing a calibration curve, urine samples of non-exposed persons were
spiked with 1-hydroxypyrene resulting in final concentrations of 2, 5, 10, 20, 40 and
400 nmol 1. and were treated as described above. A six-point standard curve was
prepared across the working range. The peak heights of the chromatograms were
used for quantification. The detection limit of the method was approximately 0.5
nmol 1. . The reproducibility of the chromatographic analysis was determined by
repeated analysis of the spiked urine samples and gave a variation coefficient of 8-
12%.
RESULTS
Personal air sampling
The results of the personal monitoring programme of each worker are shown in
Table 2. The exposure to total PAH at the different worksites of the examined
carbon anode plant varied from 3.99 to 120.6 jig PAH m~3. Worker 2, who was
mainly working in the paste plant, showed the highest exposure to total PAH with a
range of 60.53-111.5 fig m~3 and a BaP concentration from 1.37 to 4.43 fig BaP m~3
(AM = 2.6 fig BaP m"3; GM = 2.39 fig BaP m~3; N= 5). Workers 1 and 4, who had
different tasks in the anode forming section, showed a lower exposure to total PAH
Table 2. Exposure to PAHs at different worksites in the carbon anode plant
PAH*
Naph
Aceny
Ace
Flu
Phe
Ant
Fluor
Pyr
BNT
BghiFl
BcP
BaA
Chr
BjbF
BkF
BeP
BaP
Per
DacA
IND
DahA
BbC
278
BgP
ANT
Cor
Total PAH
Worker 1
1.28-11.12
0.04-0.33
5.88-25.79
1.79-5.62
2.40-5.75
0.83-1.49
1.54-5.39
1.14-3.61
0.13-0.36
0.06-0.21
0.06-0.17
0.62-1.90
0.79-2.08
0.83-2.25
0.80-1.92
0.64-1.97
0.89-3.12
0.22-0.78
0.07-0.29
0.63-1.87
0.13-0.40
0.07-0.37
0.15-0.64
0.62-2.11
0.13-O.59
0.08-0.16
30.97-69.34
Worker 2
4.85-22.00
0.07-0.44
7.88-14.51
4.45-10.45
5.16-10.67
2.76-5.51
5.67-15.70
3.87-12.84
0.48-1.04
0.19-0.47
0.21-O.51
1.88-1.65
2.06-5.45
1.78-^.83
1.24—4.32
1.01-3.83
1.37-4.43
0.37-1.14
0.09-0.45
0.89-3.99
0.20-0.96
0.09-0.51
0.23-1.20
0.95-3.24
0.09-0.62
0.06-O.41
60.53-111.5
Worker 3
3.8-9.01
0.07-0.33
7.05-11.92
1.35-8.20
2.25-3.86
0.55-1.14
0.74-1.81
0.51-1.33
0.05-0.11
0.02-0.06
0.02-0.05
0.20-0.60
0.26-0.65
0.17-0.65
0.16-0.51
0.13-0.55
0.16-0.79
0.04-0.21
0.02-0.07
0.11-0.54
0.03-0.10
0.02-0.09
0.04-O.16
0.13-0.56
0.02-0.14
0.01-0.06
22.71-35.44
Worker 4
2.37-8.26
0.04-0.18
4.65-7.06
1.46-2.72
2.82-3.68
0.57-0.76
2.76-3.65
2.48-3.86
0.30-0.56
0.15-0.34
0.14-0.29
1.64-3.51
1.79-3.90
1.91-3 71
1.59-3.18
1.51-3.27
2.12-4.88
0.58-1.24
0.25-0.49
1.61-3.50
0.35-0.83
0.31-0.60
0.54-1.07
2.01-3.24
0.35-1.02
0.22-0.42
31.55-58.16
Worker 5
GignT3)
2.41-17.58
0.06-0.94
6.04-8.26
3.31-4.98
4.56-6.15
0.77-1.60
1.16-10.82
0.91-7.95
0.03-0.73
0.02-0.28
0.02-0.37
0.14-2.62
0.18-3.16
0.17-1.97
0.12-2.01
0.14-1.50
0.17-2.03
0.05-0.52
0.02-O.15
0.11-1.32
0.02-O.31
0.01-0.17
0.04-0.30
0.11-1.17
0.02-0.24
0.02-0.14
33.52-70.10
Worker 6
(pgm"3)
1.35-10.87
0.01-0.32
0.11-10.83
0.06-12.17
0.62-15.69
0.42-1.39
0.49-11.17
0.41-10.22
0.07-1.81
0.05-0.92
0.03-O.94
0.28-7.40
0.36-10.02
0.29-4.77
0.21-4.02
0.22-3.34
0.27-3.66
0.08-1.03
0.02-O.43
0.19-2.93
0.03-O.79
0.02-0.52
0.05-1.11
0.20-3.66
0.03-0.93
0.02-0.56
3.99-120.6
*For abbreviations see Materials and Methods.
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with a concentration from 30.97 to 69.34 fig m~3 and a BaP exposure from 0.89 to
4.88 fig BaP m~3 (AM = 2.44 fig BaP m~3; GM = 2.14 fig BaP m~3; N=\G). The
crane operator of the coke store (worker 5) showed a higher variation in exposure to
total PAH than the crane operator in the store section of broken green anodes and
burned anodes (worker 3), mainly owing to his part-time activities in the paste plant.
During the week his exposure to total PAH ranged from 33.52 to 70.1 fig PAH m~3
and for BaP from 0.17 to 2.03 fig BaP m~3 (AM = 0.99 fig BaP m~3; GM = 0.72 fig
BaP m~3; N=5). Worker 3, who remained the whole shift in the crane cabin had an
exposure of 22.71-35.44 fig PAH m~3 and 0.16-0.79 fig BaP m~3 (AM = 0.39 fig
BaP m~3; GM = 0.33 fig BaP m~3; N=5), respectively. Owing to his different tasks
as overseeing, maintenance and operating functions, worker 6 showed the highest
exposure variation of all worksites. During the week his exposure to total PAH
varied from 3.99 to 120.55 fig PAH m~3 and for BaP from 0.27 to 3.66 fig BaP m~3
(AM 1.38 fig BaP m~3; GM = 0.92 fig BaP m~3; N=5).
The weekly concentration of pyrene (gaseous and particulate) at all worksites
ranged from 0.41 to 12.84 fig m . The distribution of pyrene between the gas and
the particulate phase differed for all worksites from 5.3 to 68.6% by a factor of 13. In
geometric mean, the worksites paste plant (GM = 24.6%; N=T), forming section
(GM = 21.7%; N=S) and store section (GM = 23.0%; N=l0) showed an equal
distribution.
To evaluate the suitability of the congener pyrene as a representative for total
PAH (NIOSH) and, from the toxicological point of view, for BaP and for the sum of
carcinogenic PAH (classified as animal carcinogens by the IARC: BaA, Chr, BjbF,
BkF, BaP, IND, BgP), a correlation was calculated using linear regression analysis.
This was done in order to find out if exposure to carcinogenic PAHs such as BaP can
be determined by using a marker compound such as pyrene or its metabolite 1-
hydroxypyrene. For comparison, correlation analysis for PAH air concentrations
using the Spearman rank correlation coefficient is shown, because it is often used to
assess the suitability of pyrene as an indicator for PAHs. The results of these two
correlation analyses for all worksites, the forming section and the paste plant are
shown in Table 3.
Table 3. Linear regression and Spearman
PAHs
Linear regression
BaP
Carcinogenic PAH
PAH (NIOSH)
Spearman correlation
BaP
Carcinogenic PAH
PAH (NIOSH)
All worksites
W=30)
Jc (pyrene)
0.34
0.51
0.64
coefficients
All worksites
(tf=30)
R, (pyrene)
0.76
0.83
0.78
correlation analysis of airborne
Forming section
W=8)
1c (pyrene)
0.55
0.65
0.52
Forming section
(JV=8)
fl. (pyrene)
0.74
0.79
0.93
Paste plant
(N= 10)
IC (pyrene)
0.74
0.79
0.93
Paste plant
(iV= 10)
R, (pyrene)
0.85
0.78
0.9
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Biological monitoring
The concentration of l-hydroxypyrene in the urine of each worker in the post-
and pre-shift samples was referred to creatinine. Considering all urine samples, the
creatinine concentration varied from 1 to 43 mmol I."1. Only one sample was
lower than 9 mmol I."1 and one higher than 40 mmol I."1. The background
concentration of l-hydroxypyrene in the urine was determined on the basis of the
average of the l-hydroxypyrene content in the pre-shift sample of Monday
morning before the working week and Monday morning after the working week. It
varied for the non-smokers (N=2) from 0.6 to 0.9 /anol mol"1 and for smokers
(N=4) from 0.5 to 1.5 [imo\ mol"1. The control group (employees of the company
office with no contact to PAH-containing material) showed for non-smokers
(#=5) a l-hydroxypyrene concentration of 0.2-1.2 /anol mol"1 and for smokers
(N=5) 0.2-1.3 /imol mol"1. Owing to the small number of samples, a statistical
significance of the differences between the 1-hydroxypyrene concentration in urine
of smoking and non-smoking controls could not be shown. Several authors have
found that smokers do not have a statistically significant higher l-hydroxypyrene
concentration in the urine (14). During the work week the concentration of 1-
hydroxypyrene in the post-shift samples varied from 0.5 to 61.8 /imol mol"1
creatinine and in the pre-shift samples from 0.5 to 38.9 /nnol mol"1 creatinine. In
Figs l(a)-(f) the course of urinary l-hydroxypyrene is shown for each worker.
Worker 2 in the paste plant showed the highest values during the week with a
mean post-shift concentration of 24.6 /xmol l-hydroxypyrene per mol creatinine
(GM; N=5) and a range from 14.2 to 61.8 /nnol mol"1, although his exposure to
pyrene was in the same range as that of the workers in the forming section.
Urinary l-hydroxypyrene concentration in the post-shift samples of these ranged
from 1.8 to 21.7 /anol mol"1 with a mean concentration of 4.8 /rniol mol"1 (GM;
N=5).
In the first correlation analysis, the Spearman rank correlation test was
performed to prove whether there was a correlation between respiratory PAH (for
example pyrene and BaP) exposure and the l-hydroxypyrene excretion in the post-
and pre-shift samples; see Table 4.
Toxicokinetics
Lung cancer is the dominating health effect of occupational PAH exposure. The
systemic PAH concentration, which can be expressed as urinary l-hydroxypyrene, is,
however, composed not only of inhaled but also of dermal PAH uptake. Van Rooij
et al. (1993) reported that in the case of coke workers, an average of 75% with a
range from 28 to 95% of the total absorbed amount of pyrene enters the body
through the skin. The great variability of dermal exposure of the workers makes it
difficult to calculate the inhalatory PAH uptake by determining the concentration of
l-hydroxypyrene in urine. To examine if a sufficiently precise relationship between
urinary l-hydroxypyrene excretion and inhalatory uptake of pyrene exists, a range of
individual periods was investigated and compared with the results of a pharmaco-
kinetic model.
The calculation is based on a pharmacokinetic one-compartment model with a
constant inhalatory pyrene intake (zero-order absorption) and a first-order
352 Th. Petry et al.
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Table 4. Spearman correlation analysis for airborne pyrene and BaP exposure concentrations and urinary
1-hydroxypyrcne in post- and pre-shift urine samples at the different worksites
Spearman correlation coefficients
All worksites Forming section Paste plant
(N=30) (N-&) (N=\0)
pyrenol post- pyrenol pre- pyrenol post- pyrenol pre- pyrenol post- pyrenol pre-
Pyrene(air) 0.56 0.48 0.49 0.58 0.55 0.64
BaP (air) 0.56 0.41 0.46 0.54 0.59 0.74
elimination of the 1-hydroxypyrene in the urine. The half-life of pyrene in man is
around 6-35 h (Jongeneelen et al., 1990). For this model, two different half-
lives—6 and 35 li—were used to cover the entire range. Furthermore, it was
assumed that 20% of the total pyrene intake is excreted as 1-hydroxypyrene in
urine, as estimated by Van Rooij et al. (1993). Based on a EPA model (EPA,
1989) for particle bound chemicals, the inhalatory pyrene intake was estimated
under the assumption that about 25% of inspired particles are exhaled, 12.5% are
deposited in the lower respiratory tract and 62.5% are eliminated from the lungs
and swallowed. Furthermore it was assumed that the elution of pyrene from the
deposited particles in the lower respiratory tract is 100%, and that of the
swallowed fraction of the particle bound pyrene, 40% is absorbed in the
gastrointestinal tract (Forth et al., 1988). An absorption factor of 70% of gaseous
pyrene was used. The background concentration of 1-hydroxypyrene in the urine
was estimated by the average of the 1-hydroxypyrene content in the pre-shift
samples of Monday morning before the work week and Monday morning after
the work week. In the kinetic calculation, this background concentration was
added everyday to the calculated pre- and post-shift concentration of each
worker. The calculated 1-hydroxypyrene concentrations in urine for each worker
during the whole working week are shown in Figs l(a)—(f), compared with
measured concentrations of the six workers.
DISCUSSION
Traditionally, PAH exposure is monitored via personal sampling. This is
assumed to reflect the inhalatory uptake of gaseous and particulate PAHs.
Epidemiological studies have shown a quantitative relationship between inhalatory
PAH exposure at the workplace and increased lung cancer risk. On this basis,
occupational PAH exposure is regulated in most countries with threshold limit
values based on mean airborne concentration of benzo(a)pyrene or the benzene
soluble material of coal tar pitch volatiles.
Several groups have suggested the use of the determination of a PAH metabolite
in urine as an indicator of occupational PAH exposure since this is assumed to reflect
the internal dose of PAHs. No significant relationship between systemic concentra-
tions of PAH metabolites and cancer risks has been determined by the International
Agency for Research on Cancer, however. Before establishing a biological exposure
limit (BEL) as an indicator of risk for PAH, one should ensure that the
concentration of carcinogenic PAH in the lungs (reflecting inhalatory exposure)
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can be reliably estimated on the basis of the urinary concentration of a PAH
metabolite, for example 1-hydroxypyrene.
To evaluate the suitability of pyrene as an indicator for total PAH (NIOSH) and,
from the toxicological point of view, the BaP and the sum of carcinogenic PAHs, a
linear regression analyses and the Spearman correlation test were performed on the
basis of the personal sampling data. The linear regression analyses (regression
coefficient expressed as R2, Table 3) showed a poor correlation for pyrene and BaP
air concentrations and a low correlation for pyrene and the sum of carcinogenic
PAHs, respectively, total PAH (NIOSH) for all worksites. The same results were
found at the worksites in the forming section. A higher correlation between pyrene
and BaP, respectively, the sum of carcinogenic PAHs and a good correlation
between pyrene and total PAH (NIOSH) were found at the worksites of the paste
plant. The same tendency, with a higher correlation, was found when using the
Spearman correlation test between pyrene and BaP, total PAH and the sum of
carcinogenic PAHs. The Spearman rank correlation coefficient is often used to assess
the suitability of pyrene as an indicator for PAHs. Using this test, one must consider
the fact that only the rank of the compounds and not their actual concentrations is
taken into account. It is therefore questionable whether this test is really appropriate
for the evaluation of a quantitative relationship between a substance in the air and in
the urine.
The extraction of PAH-metabolites is a result of inhalatory and dermal PAH
exposure. Since only the inhalatory exposure was measured here, a toxicokinetic
model was used to predict urinary levels and then to compare calculated and
measured values.
The comparison between measured 1-hydroxypyrene excretion and that
calculated for the workers examined [Figs l(a)-(f)] allows us to assess factors
influencing the excretion rate of 1-hydroxypyrene for each individual. Workers 1 and
4 were both working in the forming section with similar tasks (mainly truck driving).
Although their pyrene exposure was in the same range (Table 2) their measured
urinary 1-hydroxypyrene excretion during the working differed considerably [see
Figs l(a) and (d)]. Observation and questioning of both workers led to the
conclusion that dermal exposure and varying smoking habits (both were smokers)
would not explain this difference. It could be stressed that in the case of worker 1,
physiological factors are responsible for this variability of urinary 1-hydroxypyrene
excretion. Intensive dermal contact to PAH-containing material is assumed to be
responsible for the difference between measured and calculated excretion course of
worker 2 [Fig. l(b)] who was working in the paste plant. However, there is no
uniformity between the excretion calculated on the basis of his relative constant
respiratory pyrene exposure and the measured 1-hydroxypyrene concentrations
before and after the shifts. This leads to the conclusion that the daily dermal
exposure varies considerably and thus greatly influences the daily excretion rate of 1-
hydroxypyrene. On the other hand, the example of worker 6 [Fig. l(f)] should be
mentioned. In this case, a good concordance between estimated and measured 1-
hydroxypyrene excretion during the work week was found. Because of his overseeing
functions, this worker was assumed to have a minimal dermal exposure. In
summary, these comparisons suggest that individual 1-hydroxypyrene excretion
varies considerably from case to case. At the same workplace, the urinary excretion
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of 1-hydroxypyrene differed up to a factor of 5 between workers with virtually the
same pyrene exposure and an assumed low dermal exposure. Worksites where
dermal exposure seems to be the most important route of entry of PAHs into the
body, workers 1-hydroxypyrene excretion underlies a variability of factor 5-10
during a work week.
Data on dermal exposure are limited and the existing studies show a high
variability of individual 1-hydroxypyrene elimination depending on worksites,
protective measures, personal hygiene and physiological factors. It is, therefore,
questionable whether a reliable mean dermal exposure for different processes at
different worksites can be established. Indeed, as reported by Van Rooij et al. (1993),
75% of the total absorbed pyrene enters the body via the skin in the case of coke
oven workers. Though the extent of dermal absorption is affected by a series of
factors relating to the chemical itself or to the characteristics of the skin (Ecetoc,
1993), it is not yet clear how the absorption flux of a non-carcinogenic four-ring
congener, such as pyrene, as measured with urinary 1-hydroxypyrene differs from
that of carcinogenic five-seven-ring congeners, such as benzo(a)pyrene or
dibenzo(a,h)anthracene, for example. With the isolated blood-perfused pig ear
model Van Rooij (1994) estimated that the percutaneous absorption of PAH with a
higher molecular weight than pyrene are overestimated by a factor of 7 for
benzo(a)pyrene and up to a factor of 100 for indeno(1.2.3-cd)pyrene. The authors
concluded that it is probably also valid for dermal PAH absorption in man. To date,
no confirmation of this supposition, which is of great importance for risk assessment
of cancer, is available.
Comparison of the measured and the calculated excretion courses of 1-
hydroxypyrene in this investigation showed the influence of different factors on
individual urinary 1-hydroxypyrene excretion. Non-concordant behaviour is not a
consequence of incorrect pharmacokinetic parameters in the model, since changes
in parameters would always change the points on the curve in the same direction.
The extremely discordant behaviour observed must, therefore, be the consequences
of individual differences in dermal PAH exposure, physiological factors or in
personal habits. From the toxicological and medical point of view, lung cancer is
the dominating health effect of occupational PAH exposure. Since the ratio of
airborne pyrene to one or more carcinogenic PAHs varies from one process to
another and no consistency in the relative contribution of dermal and inhalatory
PAH exposure can be seen, the determination of urinary 1-hydroxypyrene is not
valid for characterizing the respiratory exposure to PAHs of individuals.
Knowledge of the inhalatory PAH exposure is however indispensable for the
assessment of health risk.
The determination of the concentration of 1-hydroxypyrene in urine seems,
therefore, to be suitable to assess the general PAH exposure of workers in
comparable processes. The large number of samples in this case allowing individual
variations to be balanced out. For a valid assessment of the individual lung cancer
risk, however, it cannot replace personal air monitoring because of the important
influence of so many confounding factors. Although personal air monitoring does
not take into account measures such as wearing facial protective clothing, it reflects
more reliably the individual inhalatory PAH uptake, which is still the most relevant
for possible health effects.
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